ARCHIVES

Radium-233 Dichloride Increased Overall Survival in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

FDA News: Consolidation Plan Designed For Savings

June 5, 1998

Individualized Cancer Vaccines Show 90% Survival at 6 Months

December 27, 2013

Senate approves NIH funding bill. NCI awards $25 million to eight institutions for patient navigator programs; $35 million awarded for nanotechnology partnerships.

October 28, 2005

New RFAs Released: Kaposi Sarcoma; Rare Tumors; Biochemical Epidemiology; Dietary Questionnaire; Role of Nicotine

August 20, 1982

Stem Cell Transplant More Effective than Chemotherapy

April 25, 2003

Three CBCCPs Say They’ll Appeal To NC On Termination

March 21, 1980